Provided by Tiger Trade Technology Pte. Ltd.

Veracyte

40.87
-1.1600-2.76%
Post-market: 40.870.00000.00%19:30 EDT
Volume:1.00M
Turnover:41.20M
Market Cap:3.29B
PE:29.31
High:42.66
Open:42.61
Low:40.79
Close:42.03
52wk High:60.91
52wk Low:29.46
Shares:80.39M
Float Shares:78.97M
Volume Ratio:1.02
T/O Rate:1.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.39
EPS(LYR):0.8200
ROE:8.77%
ROA:4.09%
PB:2.37
PE(LYR):49.84

Loading ...

UBS Adjusts Price Target on Veracyte to $52 From $48, Maintains Buy Rating

MT Newswires Live
·
May 06

Stock Track | Veracyte Soars 13.77% in Pre-market on Strong Q1 Earnings Beat and Raised 2026 Guidance

Stock Track
·
May 06

Stock Track | Veracyte Soars 7.73% on Strong Q1 Earnings Beat and Raised 2026 Guidance

Stock Track
·
May 06

Veracyte Inc Earnings Call Signals Profitable Growth

TIPRANKS
·
May 06

Veracyte Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
May 06

Stock Track | Veracyte Soars 16.73% After-Hours on Strong Q1 Results and Raised Guidance

Stock Track
·
May 06

Veracyte Q1 FY26 net income rises 307% to $28.7 million; revenue climbs 21% to $139.1 million

Reuters
·
May 06

Veracyte Q1 Adj. EPS $0.52 Beats $0.15 Estimate, Sales $139.071M Beat $130.041M Estimate

Benzinga Earnings
·
May 06

BRIEF-Veracyte Q1 Revenue USD 139.1 Million Vs. IBES Estimate USD 130 Million

Reuters
·
May 06

Veracyte Outlook FY Revenue Growth 13-14%

THOMSON REUTERS
·
May 06

Veracyte Inc - Raises 2026 Adj Ebitda Margin Guidance to Greater Than 26%

THOMSON REUTERS
·
May 06

Veracyte Outlook FY Revenue USD 582-592 Million

THOMSON REUTERS
·
May 06

Earning Preview: Veracyte revenue is expected to increase by 17%, and institutional views are bullish

Earnings Agent
·
Apr 28

Veracyte announces new data at AUA 2026 on Decipher portfolio

TIPRANKS
·
Apr 28

Veracyte highlights Decipher Bladder data on chemo-immunotherapy response at AUA 2026

Reuters
·
Apr 28

Veracyte Is Maintained at Hold by Canaccord Genuity

Dow Jones
·
Apr 21

Press Release: Veracyte to Release First Quarter 2026 Financial Results on May 5, 2026

Dow Jones
·
Apr 15

Veracyte schedules quarterly results conference call and webcast

Reuters
·
Apr 15

Veracyte Initiated at Buy by Jefferies

Dow Jones
·
Apr 13

Jefferies Initiates Veracyte at Buy With $45 Price Target

MT Newswires Live
·
Apr 13